Novel transcript antisense to MPP5

ENSG00000286319 is an uncharacterized long non-coding RNA annotated as "novel transcript, antisense to MPP5." Natural antisense transcripts like this are widespread in mammalian genomes and often overlap protein-coding genes in the opposite orientation[5]. These antisense RNAs can regulate their sense counterparts through multiple mechanisms, including modulation of chromatin structure, transcriptional interference, or RNA stability[1][3][5]. In this case, the transcript is located antisense to the MPP5 gene, but it lacks evidence of protein-coding potential or established biological function. Such entries are often preliminary annotations based on transcriptomic data and require further characterization. Antisense RNAs are not considered classical therapeutic targets (such as receptors, enzymes, or transporters) and have no known associated drugs or direct disease links[5][1][3]. The scientific community generally does not consider entries like ENSG00000286319 as validated molecular targets. Clarification of reliability: - This transcript is not a validated therapeutic target in current biomedical literature or drug databases. - The annotation is a computational prediction (as suggested by the generic name "novel transcript..."), with no established role, function, or associated drug targets. - While antisense RNAs are important in gene regulation, most annotated "novel" antisense transcripts, including this one, remain functionally uncharacterized and should not be considered actionable drug targets without further validation[5][1][3]. - There is nothing misspelled in the entry, but it is not a formal target according to drug discovery standards. If you need information on a protein-coding target, it is advisable to use a well-characterized gene or protein entry, such as MPP5 itself, rather than this antisense transcript.

Other names

ENSG00000286319antisense RNA to MPP5natural antisense transcript to MPP5